Abstract
Alzheimer’s disease (AD) is a genetically complex and heterogeneous disorder. Recent estimates suggest that possibly over 70% of the genetic variance for the disease remains unaccounted for by apolipoprotein E (APOE) and the three known early-onset AD genes (APP, PSEN1, PSEN2). Specifically, one recent segregation analysis predicted the existence of up to four additional susceptibility genes having a similar or greater effect than APOE. However, most of the nearly three dozen putative AD loci proposed to date have only been inconsistently replicated in follow up analyses and more studies are necessary to distinguish false-positive findings from genuine signals. Novel AD genes will not only provide valuable clues for the development of novel therapeutic approaches, but will also allow the development of new genetic risk-rofiling strategies that are an essential prerequisite for early prediction/prevention of this devastating disease. In this review, we will present a brief overview of analytic tools in complex disease genetics, as well as a summary of recent linkage and association findings indicating the existence of novel late-onset AD genes on chromosomes 12, 10, and 9.
Similar content being viewed by others
References
Alvarez V., Alvarez R., Lahoz C. H., et al. (1999) Association between an alpha(2) macroglobulin DNA polymorphism and late-onset Alzheimer’s disease. Biochem. Biophys. Res. Commun. 264, 48–50.
Arinami T., Takekoshi K., Yanagi H., et al. (1996) The 5-repeat allele in the very-low-density lipoprotein receptor gene polymorphism is not increased in sporadic Alzheimer’s disease in Japanese. Neurology 47, 1349–1350.
Baum L., Dong Z. Y., Choy K. W., et al. (1998) Low density lipoprotein receptor related protein gene amplification and 766T polymorphism in astrocytomas. Neurosci. Lett. 256, 5–8.
Bertram L., Blacker D., Crystal A., et al. (2001) Candidate genes showing no evidence of association with AD: results of the NIMH-AD Genetics Initiative, in Alzheimer’s Disease: Advances in Etiology, Pathogenesis and Therapeutics (Iqbad. K., Sisodia S., and Winblad B., eds.), Chichester, U K, J. Wiley & Sons, Ltd., pp. 45–53.
Bertram L., Blacker D., Crystal A., et al. (2000a). Candidate genes showing no evidence for association or linkage with Alzheimer’s disease using family-based methodologies. Exp. Gerontol. 35, 1353–1361.
Bertram L., Blacker D., Mullin K., et al. (2000b) Evidence for genetic linkage of Alzheimer’s disease to chromosome 10q. Science 290, 2302–2303.
Bertram L. and Tanzi R. E. (2001) Of replications and refutations: the status of Alzheimer’s disease genetics research. Curr. Neurol. Neurosci. Rep. 1, 442–450.
Blacker D., Haines J. L., Rodes L., et al. (1997) ApoE-4 and age at onset of Alzheimer’s disease: the NIMH genetics initiative. Neurology 48, 139–147.
Blacker D., Wilcox M. A., Laird N. M., et al. (1998) Alpha-2 macroglobulin is genetically associated with Alzheimer’s disease. Nat. Genet. 19, 357–360.
Bullido M. J., Artiga M. J., Recuero M., et al. (1998) A polymorphism in the regulatory region of APOE associated with risk for Alzheimer’s dementia. Nat. Genet. 18, 69–71.
Corder E. H., Saunders A. M., Risch N. J., et al. (1994) Protective effect of apolipoprotein E type 2 allele for late onset Alzheimer disease. Nat. Genet. 7, 180–184.
Daw E. W., Payami H., Nemens E. J., et al. (2000) The number of trait loci in late-onset Alzheimer disease. Am. J. Hum. Genet. 66, 196–204.
Dodel R. C., Du Y., Bales K. R., et al. (2000) Alpha2 macroglobulin and the risk of Alzheimer’s disease. Neurology 54, 438–442.
Durner M., Vieland V. J., and Greenberg D. A. (1999) Further evidence for the increased power of LOD scores compared with nonparametric methods. Am. J. Hum. Genet. 64, 281–289.
Ertekin-Taner N., Graff-Radford N., Younkin L. H., et al. (2000) Linkage of plasma Abeta42 to a quantitative locus on chromosome 10 in late-onset Alzheimer’s disease pedigrees. Science 290, 2303–2304.
Fallin D., Cohen A., Essioux L., et al. (2001) Genetic analysis of case/control data using estimated haplotype frequencies: application to APOE locus variation and Alzheimer’s disease. Genome Res. 11, 143–151.
Fallin D., Gauntlett A. C., Scibelli P., et al. (1997) No association between the very low density lipoprotein receptor gene and late-onset Alzheimer’s disease nor interaction with the apolipoprotein E gene in population-based and clinic samples. Genet. Epidemiol. 14, 299–305.
Farrer L. A., Cupples L. A., Haines J. L., et al. (1997) Effects of age, sex, and ethnicity on the association between apolipoprotein E genotype and Alzheimer disease. A meta-analysis. APOE and Alzheimer Disease Meta Analysis Consortium. JAMA 278, 1349–1356.
Feuk L., Prince J. A., Breen G., et al. (2000) apolipoprotein-E dependent role for the FAS receptor in early onset Alzheimer’s disease: finding of a positive association for a polymorphism in the TNFRSF6 gene. Hum. Genet. 107, 391–396.
Goate A., Chartier-Harlin M. C., Mullan M., et al. (1991) Segregation of a missense mutation in the amyloid precursor protein gene with familial Alzheimer’s disease. Nature 349, 704–706.
Greenberg D. A., Abreu P., and Hodge S. E. (1998). The power to detect linkage in complex disease by means of simple LOD-score analyses. Am. J. Hum. Genet. 63, 870–879.
NIMH Genetics Initiative AD Study Group (submitted). Results of a high resolution genome screen of 437 Alzheimer’s disease families: The NIMH Genetics Initiative.
Helbecque N., Berr C., Cottel D., et al. (2001) VLDL receptor polymorphism, cognitive impairment, and dementia. Neurology 56, 1183–1188.
Helbecque N., Richard F., Cottel D., et al. (1998) The very low density lipoprotein (VLDL) receptor is a genetic susceptibility factor for Alzheimer disease in a European Caucasian population. Alzheimer Dis. Assoc. Disord. 12, 368–371.
Jhoo J. H., Kim K. W., Lee D. Y., et al. (2001) Association of alpha-2-macroglobulin deletion polymorphism with sporadic Alzheimer’s disease in Koreans. J. Neurol. Sci. 184, 21–25.
Kamboh M. I., Ferrell R. E., and DeKosky S. T. (1998) Genetic association studies between Alzheimer’s disease and two polymorphisms in the low density lipoprotein receptor-related protein gene. Neurosci. Lett. 244, 65–68.
Kang D. E., Saitoh T., Chen X., et al. (1997) Genetic association of the low-density lipoprotein receptor-related protein gene (LRP), an apolipoprotein E receptor, with late-onset Alzheimer’s disease. Neurology 49, 56–61.
Kehoe P., Wavrant-De Vrieze F., Crook R., et al. (1999) A full genome scan for late onset Alzheimer’s disease. Hum. Mol. Genet. 8, 237–245.
Koster M. N., Dermaut B., Cruts M., et al. (2000) The alpha2-macroglobulin gene in AD: a population-based study and meta-analysis. Neurology 55, 678–684.
Lambert J. C., Berr C., Pasquier F., et al. (1998a). Pronounced impact of Th1/E47cs mutation compared with -491 AT mutation on neural APOE gene expression and risk of developing Alzheimer’s disease. Hum. Mol. Genet. 7, 1511–1516.
Lambert J. C., Goumidi L., Vrieze F. W., et al. (2000) The transcriptional factor LBP-1c/CP2/LSF gene on chromosome 12 is a genetic determinant of Alzheimer’s disease. Hum. Mol. Genet. 9, 2275–2280.
Lambert J. C., Wavrant-De Vrieze F., Amouyel P., et al. (1998b) Association at LRP gene locus with sporadic late-onset Alzheimer’s disease. Lancet 351, 1787–1788.
Lander E. and Kruglyak L. (1995) Genetic dissection of complex traits: guidelines for interpreting and reporting linkage results. Nat. Genet. 11, 241–247.
Levy-Lahad E., Wasco W., Poorkaj P., et al. (1995) Candidate gene for the chromosome 1 familial Alzheimer’s disease locus. Science 269, 973–977.
Liao A., Nitsch R. M., Greenberg S. M., et al. (1998) Genetic association of an alpha2-macroglobulin (Val1000lle) polymorphism and Alzheimer’s disease. Hum. Mol. Genet. 7, 1953–1956.
Majores M., Bagli M., Papassotiropoulos A., et al. (2000) Allelic association between the D10S1423 marker and Alzheimer’s disease in a German population. Neurosci. Lett. 289, 224–226.
Martin E. R., Lai E. H., Gilbert J. R., et al. (2000) SNPing away at complex diseases: analysis of single-nucleotide polymorphisms around APOE in Alzheimer disease. Am. J. Hum. Genet. 67, 383–394.
McIlroy S. P., Vahidassr M. D., Savage D. A., et al. (1999) Risk of Alzheimer’s disease is associated with a very low-density lipoprotein receptor genotype in Northern Ireland. Am. J. Med. Genet. 88, 140–144.
Meyer M. R., Tschanz J. T., Norton M. C., et al. (1998) APOE genotype predicts when—not whether—one is predisposed to develop Alzheimer disease. Nat. Genet. 19, 321–322.
Myers A., Holmans P., Marshall H., et al. (2000) Susceptibility locus for Alzheimer’s disease on chromosome 10. Science 290, 2304–2305.
Myllykangas L., Polvikoski T., Sulkava R., et al. (1999) Genetic association of alpha2-macroglobulin with Alzheimer’s disease in a Finnish elderly population. Ann. Neurol. 46, 382–390.
Nacmias B., Latorraca S., Piersanti P., et al. (1995). ApoE genotype and familial Alzheimer’s disease: a possible influence on age of onset in APP717 Val→lle mutated families. Neurosci. Lett. 183, 1–3.
Nacmias B., Tedde A., Cellini E., et al. (2001) alpha2-Macroglobulin polymorphisms in Italian sporadic and familial Alzheimer’s disease. Neurosci. Lett. 299, 9–12.
Okuizumi K., Onodera O., Namba Y., et al. (1995) Genetic association of the very low density lipoprotein (VLDL) receptor gene with sporadic Alzheimer’s disease. Nat. Genet. 11, 207–209.
Ott J. (1999) Analysis of Human Genetic Linkage. Johns Hopkins University Press, Baltimore, MD.
Pericak-Vance M. A., Bass M. P., Yamaoka L. H., et al. (1997) Complete genomic screen in late-onset familial Alzheimer disease. Evidence for a new locus on chromosome 12. JAMA 278, 1237–1241.
Pericak-Vance M. A., Bebout J. L., Gaskell P. C., et al. (1991) Linkage studies in familial Alzheimer disease: evidence for chromosome 19 linkage. Am. J. Hum. Genet. 48, 1034–1050.
Pericak-Vance M. A., Grubber J., Bailey L. R., et al. (2000) Identification of novel genes in late-onset Alzheimer’s disease. Exp. Gerontol. 35, 1343–1352.
Poirier J. (2000) Apolipoprotein E and Alzheimer’s disease. A role in amyloid catabolism. Ann. NY Acad. Sci. 924, 81–90.
Pritchard M. L., Saunders A. M., Gaskell P. C., et al. (1996) No association between very low density lipoprotein receptor (VLDL-R) and Alzheimer disease in American Caucasians. Neurosci. Lett. 209, 105–108.
Risch N. and Merikangas K. (1996) The future of genetic studies of complex human diseases. Science 273, 1516–1517.
Risch N. J. (2000) Searching for genetic determinants in the new millennium. Nature 405, 847–856.
Rogaev E. I., Sherrington R., Rogaeva E. A., et al. (1995) Familial Alzheimer’s disease in kindreds with missense mutations in a gene on chromosome 1 related to the Alzheimer’s disease type 3 gene. Nature 376, 775–778.
Rogaeva E., Premkumar S., Song Y., et al. (1998) Evidence for an Alzheimer disease susceptibility locus on chromosome 12 and for further locus heterogeneity. JAMA 280, 614–618.
Romas S. N., Mayeux R., Rabinowitz D., et al. (2000) The deletion polymorphism and Val1000lle in alpha-2-macroglobulin and Alzheimer disease in Caribbean Hispanics. Neurosci. Lett. 279, 133–136.
Roses A. D., Devlin B., Coneally P. M., et al. (1995) Measuring the genetic contribution of APOE in late-onset Alzheimer disease. Am. J. Hum. Genet. Suppl. 57, A202.
Satten G. A., Flanders W. D., and Yang Q. (2001) Accounting for unmeasured population substructure in case-control studies of genetic association using a novel latent-class model. Am. J. Hum. Genet. 68, 466–477.
Saunders A. M., Strittmatter W. J., Schmechel D., et al. (1993) Association of apolipoprotein E allele epsilon 4 with late-onset familial and sporadic Alzheimer’s disease. Neurology 43, 1467–1472.
Schmechel D. E., Saunders A. M., Strittmatter W. J., et al. (1993) Increased amyloid beta-peptide deposition in cerebral cortex as a consequence of apolipoprotein E genotype in late-onset Alzheimer disease. Proc. Natl. Acad. Sci. USA 90, 9649–9653.
Scott W. K., Grubber J., Coneally P. M., et al. (2000) Fine-mapping of the chromosome 12 Alzheimer disease locus using family-based association tests of microsatellite markers. Neurobiol. Aging 21, S129.
Scott W. K., Yamaoka L. H., Bass M. P., et al. (1998) No genetic association between the LRP receptor and sporadic or late-onset familial Alzheimer disease. Neurogenetics 1, 179–183.
Sherrington R., Rogaev E. I., Liang Y., et al. (1995) Cloning of a gene bearing missense mutations in early-onset familial Alzheimer’s disease. Nature 375, 754–760.
Spielman R. S., McGinnis R. E., and Ewens W. J. (1993) Transmission test for linkage disequilibrium: the insulin gene region and insulin-dependent diabetes mellitus (IDDM). Am. J. Hum. Genet. 52, 506–516.
Strittmatter W. J., Saunders A. M., Schmechel D., et al. (1993) Apolipoprotein E: high-avidity binding to beta-amyloid and increased frequency of type 4 allele in late-onset familial Alzheimer disease. Proc. Natl. Acad. Sci. USA 90, 1977–1981.
Tanzi R. E. (1999) A genetic dichotomy model for the inheritance of Alzheimer’s disease and common age-related disorders. J. Clin. Invest. 104, 1175–1179.
Tanzi R. E., Gusella J. F., Watkins P. C., et al. (1987) Amyloid beta protein gene: cDNA, mRNA distribution, and genetic linkage near the Alzheimer locus. Science 235, 880–884.
Taylor A. E., Yip A., Brayne C., et al. (2001) Genetic association of an LBP-1c/CP2/LSF gene polymorphism with late onset Alzheimer’s disease. J. Med. Genet. 38, 232–233.
Vekrellis K., Ye Z., Qiu W. Q., et al. (2000) Neurons regulate extracellular levels of amyloid beta-protein via proteolysis by insulin-degrading enzyme. J. Neurosci. 20, 1657–1665.
Verpillat P., Bouley S., Hannequin D., et al. (2000) Alpha2-macroglobulin gene and Alzheimer’s disease: confirmation of association by haplotypes analyses. Ann. Neurol. 48, 400–402.
Woodward R., Singleton A. B., Gibson A. M., et al. (1998) LRP gene and late-onset Alzheimer’s disease. Lancet 352, 239–240.
Wu W. S., Holmans P., Wavrant-DeVrieze F., et al. (1998) Genetic studies on chromosome 12 in late-onset Alzheimer disease. JAMA 280, 619–622.
Zubenko G. S., Hughes H. B., Stiffler J. S., et al. (1998) A genome survey for novel Alzheimer disease risk loci: results at 10-cM resolution. Genomics 50, 121–128.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Bertram, L., Tanzi, R.E. Dancing in the dark?. J Mol Neurosci 17, 127–136 (2001). https://doi.org/10.1385/JMN:17:2:127
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1385/JMN:17:2:127